SCHEMBL9345335

SCHEMBL9345335

CCOC(=O)CCc1ccc(OC(C)=O)c(OC(C)=O)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.56
CYP4A11 Q02928 1/20 0.56
TRPV1 Q8NER1 1/20 0.53
CCR5 P51681 6/20 0.52
LTA4H P09960 2/20 0.49
ALOX15 P16050 2/20 0.47
TNF P01375 1/20 0.46
AKT1 P31749 1/20 0.46
CYP4Z1 Q86W10 1/20 0.46
PTGS1 P23219 1/20 0.46
ADRB2 P07550 1/20 0.45
ADRA2A P08913 1/20 0.45
DRD2 P14416 1/20 0.45
ADRA2C P18825 1/20 0.45
DRD1 P21728 1/20 0.45
ADRA1A P35348 1/20 0.45
DRD3 P35462 1/20 0.45
PDE3B Q13370 1/20 0.44
PDE3A Q14432 1/20 0.44
P2RY12 Q9H244 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27328511 0.85 TRPV1 (0.52) CYP4F2CYP4A11TRPV1CCR5LTA4H
SCHEMBL2417527 0.85 PTGS1 (0.48) CYP4F2CYP4A11TRPV1CCR5ALOX15
SCHEMBL3351439 0.84 CASR (0.50) CYP4F2CYP4A11TRPV1CCR5LTA4H
SCHEMBL178977 0.82 TRPV1 (0.57) CYP4F2CYP4A11TRPV1CCR5LTA4H
SCHEMBL491276 0.82 CYP4F2 (0.59) CYP4F2CYP4A11LTA4HDRD2
SCHEMBL2848440 0.82 CYP4F2 (0.59) CYP4F2CYP4A11CYP4Z1
SCHEMBL10338797 0.81 CCR5 (0.57) CYP4F2CYP4A11TRPV1CCR5LTA4H
SCHEMBL9588895 0.81 TRPV1 (0.60) CYP4F2CYP4A11TRPV1CCR5LTA4H
SCHEMBL10439122 0.80 TRPV1 (0.53) CYP4F2CYP4A11TRPV1CCR5LTA4H
SCHEMBL178978 0.79 TRPV1 (0.58) CYP4F2CYP4A11TRPV1CCR5LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0333522-B1 Catechol derivatives and pharmaceutical preparations containing same MITSUI TOATSU CHEMICALS (JP) 1994-08-17 EP disclosed
US-5232923-A Stimulates production of nerve growth factor; administering for treatment of regressive disorders of the central nervous system MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1993-08-03 US disclosed
EP-0333522-A2 Catechol derivatives and pharmaceutical preparations containing same MITSUI TOATSU CHEMICALS, Inc. (JP) 1989-09-20 EP disclosed